SCHEMBL8327123

SCHEMBL8327123

CCOC(=O)n1ccc(=O)c2cc(F)c(Cl)nc21

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 3/20 0.37
▸ NPC1 O15118 1/20 0.35
▸ RAB9A P51151 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ CYP1A2 P05177 3/20 0.35
▸ ALDH1A1 P00352 3/20 0.35
▸ CYP2C9 P11712 2/20 0.35
▸ KDM4E B2RXH2 2/20 0.35
▸ GLA P06280 1/20 0.35
▸ CYP2C19 P33261 1/20 0.35
▸ TNF P01375 1/20 0.34
▸ BRD4 O60885 1/20 0.34
▸ BRD2 P25440 1/20 0.34
▸ BRD3 Q15059 1/20 0.34
▸ CREBBP Q92793 1/20 0.34
▸ LPO P22079 3/20 0.34
▸ LMNA P02545 3/20 0.34
▸ HPGD P15428 2/20 0.34
▸ L3MBTL1 Q9Y468 1/20 0.34
▸ HSD17B10 Q99714 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9837290 0.76 HDAC6 (0.34) KMT2ACYP2C9LMNAKEAP1NFE2L2
SCHEMBL12684180 0.69 LPO (0.38) KMT2ARAB9ASMN1; SMN2CYP1A2ALDH1A1
SCHEMBL29722269 0.69 LPO (0.35) KMT2ARAB9ASMN1; SMN2CYP1A2ALDH1A1
SCHEMBL23147508 0.69 LPO (0.35) KMT2ARAB9ASMN1; SMN2CYP1A2ALDH1A1
SCHEMBL3977245 0.69 ALDH1A1 (0.53) KMT2ANPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL12009953 0.69 PARP1 (0.40) KMT2ARAB9ASMN1; SMN2CYP1A2LPO
SCHEMBL4827306 0.69 RAB9A (0.40) KMT2ARAB9ASMN1; SMN2CYP1A2ALDH1A1
SCHEMBL8091107 0.68 NPC1 (0.48) KMT2ANPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL9536041 0.68 NPC1 (0.46) KMT2ANPC1ALDH1A1KDM4ECYP2C19
SCHEMBL19986908 0.68 ALDH1A1 (0.49) KMT2ANPC1SMN1; SMN2ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0930297-A1 A process for preparing naphthyridones and intermediates Pfizer Products Inc. (US) 1999-07-21 — — EP disclosed
Send feedback